Find clinical trials for COVID-19 in San Francisco, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near San Francisco, CA, USA:
by whole-body PET-CT imaging in participants with convalescent COVID-19. Up to 80 participants will be enrolled over an accrual per...
Phase 2
San Francisco, California, United States
This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...
Phase 4
Walnut Creek, Colorado, United States of America and 98 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
San Francisco, California, United States and 224 other locations
The purpose of this study is to learn about the safety and effects of an updated COVID-19 vaccine (called BNT162b2) in adults 18 to-...
Phase 4
Walnut Creek, California, United States and 4 other locations
This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health proble-...
Phase 3
Walnut Creek, Colorado, United States of America and 199 other locations
There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based thera...
Palo Alto, California, United States and 2 other locations
This study will test the safety and tolerability of Anktiva in patients with Long Covid. Eligible patients will receive up to 2 doses of Anktiva and...
Phase 2
San Francisco, California, United States
Persistent viral infection with viral reservoirs and detection of circulating spike protein after the initial acute illness is one potential pathogen...
Phase 2
San Francisco, California, United States
Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluat...
Phase 2
San Francisco, California, United States and 19 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...
Phase 3
San Francisco, California, United States of America and 246 other locations
Clinical trials
Research sites
Resources
Legal